SGLT2 Inhibitors and Other Classes of Therapies in HFpEF: Examining The Totality of Clinical Data

Drs Lam, Anker, and Bozkurt discuss the most recent data on the management of patients with HFpEF. Credit available for this activity expires: 12/23/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965198?src=mkm_podcast_addon_965198